This is a problem we call the Quality-Price Gap. We put Hers under the microscope to see how it measures up on safety, cost, and long-term support, helping you bridge the gap between safety and affordability
In people with DKD, the once-weekly GLP-1 receptor agonist dulaglutide increased mGFR (37), although semaglutide appeared to initially reduce eGFR (15)
Other perks include app-based features like real-time insurance process tracking and treatment notifications, side effect guidance and FAQs, educational materials, and more
Molecular integration of incretin and glucocorticoid action reverses immunometabolic dysfunction and obesity
In general, weight loss medications are recommended for people who: Have a body mass index (BMI) of 30 or higher Have a BMI of 27 or higher, plus a weight-related condition like high blood pressure or type 2 diabetes Find out how much you could lose Provide your biometric data to get started
Complete prevention is not guaranteed, but you can significantly reduce your risk and severity